A new clinical study shows that an inhibitor of Fas ligand (FasL), also called CD95 ligand (CD95L), led to a faster recovery ...
The virus takes control of three key host proteins that suppress the activity of the complement system. Researchers at the ...
Discover groundbreaking research from Emory University that has revealed that autoantibodies found in the nasal cavity may ...
PT Fast Food Indonesia Tbk (FAST), the licensee owner of Kentucky Fried Chicken (KFC) in Indonesia, recorded a loss of Rp558 ...
A study published in the journal Frontiers of Medicine has found an association between the inactivated COVID-19 vaccine CoronaVac from Sinovac ... normal values for ADAMTS13 antigen and inhibitory ...
COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...
New research is providing a more precise prediction of COVID-19 severity that can be found by looking at autoantibodies in the nasal cavity, leading to more personalized treatment plans.
Involving a new research tool named FlowBEAT, a study in Science Translational Medicine links self-targeting antibodies in ...
COVID-19 presents a broad range of symptoms, varying in intensity from mild to severe and even life-threatening.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback